Editorial · 2019
Research articlePublished 2014
Heterogeneity of The CD90+ Population in Different Stages of Hepatocarcinogenesis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
We have characterized herein the heterogeneity of the CD90+ population at each stage of hepatocarcinogenesis using a computer-assisted immunohistochemical staining evaluation method for quantitative analysis on tissue microarrays. We found that CD90 in Hepatocellular carcinoma (HCC) tissues, which has been shown to be a marker for cancer stem cells, is expressed on tumor cells, in the stroma or on endothelial cells. Sub-classification of the CD90+ population was based on morphology and co-expression with known markers including CD45 and CD31. Multiple linear regression suggested that the percentage of CD90+ cancer cells/hepatocyte (p<0.0001), level of overall CD90 expression (p<0.0014), and level of CD90 expression in tumor islands (p<0.0001) increased significantly in each stage of liver disease progression, while the level of stromal CD90 expression (p=0.1129) did not change significantly. Additionally, only the CD90+ cancer cells were positive for other cancer stem cell (CSC) markers including CD24, CD44 and CD133 whereas the other CD90+ cells were negative for these markers. CD90 expression in cirrhosis was observed in hepatocytes, the portal tract area and fibrous septa while CD90 expression in normal liver was limited only to the portal tract area. This study demonstrates the heterogeneity of the CD90+ population in HCC where a small population of the CD90+ cells that expressed other CSC markers are CSCs and are associated with advanced stages of hepatocarcinogenesis. This heterogeneity should be emphasized in further studies where other methods may not be able to discriminate these distinct types of CD90+ cells.
Subjects
Biochemistry & BiotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 20 Mar 2017
Human umbilical cord derived CD73, CD90 and CD105 positive mesenchymal stem cells differentiated into pancreatic β cells: Implications in diabetic therapy
Research article · 28 Dec 2016
CD90-Targeted Liposomes Increase the Therapeutic Efficacy of a Retinoic Acid Derivative in Pulmonary Carcinoma
Research article · 2018
Periostin is Secreted by Glioblastoma CD90-positive Stromal Cells and Acts as a Pericyte Chemoattractant
Conference abstract · 9 May 2016
YAP signalling deregulation and genetic susceptibility to hepatocarcinogenesis, stemness and aggressivity of liver cancer
More from this journal
The newest in Journal of Proteomics & Bioinformatics.
Perspective · 30 Dec 2025
Advances in Molecular Docking for Predicting Protein Ligand Interactions
Commentary · 30 Dec 2025
Machine Learning in Bioinformatics Transforming Biological Data into Predictive Insights
Perspective · 30 Dec 2025
Post-Translational Modifications as Dynamic Regulators of Proteome Complexity and Cellular Function
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Proteomics & Bioinformatics
- SubjectBiochemistry & Biotechnology
- BylineArticles whose byline prints “Smathorn Thakolwiboon”
- BylineArticles whose byline prints “Jianhui Zhu”
- BylineArticles whose byline prints “Qixing Liang”
- BylineArticles whose byline prints “Theodore H Welling”
- BylineArticles whose byline prints “Min Zhang”
- BylineArticles whose byline prints “David M Lubman”

